m.net/ireye/confLobby. is a biopharmaceutical company engaged in the
discovery and development of drugs for the treatment of human viral and other
infectious diseases. Idenix 's current focus is on the treatment of infections
caused by hepatitis B virus, hepatitis C virus and human immunodeficiency
virus (HIV).

Business Editors/Health/Medical Writers
BIOWIRE2K

SAN FRANCISCO----The Institute for
OneWorld Health, the first nonprofit pharmaceutical company in the
U.

CEL-1000 Peptide Effective Against Viral Encephalitis in Mice

government's list of priority
pathogens for bio-defense research.
The work was conducted with the support of two grants from the National
Institute of Allergy and Infectious Diseases (NIAID). These include: The West
Nile Virus and three viruses that the U. Neena Goel had shown high levels of protection
in animal studies against Herpes Simplex Virus. The Company has operations in Vienna,
Virginia and Baltimore, Maryland .

When used in this report, the words "intends," "believes," "anticipated"
and "expects " and similar expressions are intended to identify forward-looking
statements.

viral spirochetal

"This generous grant from the Sapling Foundation will allow
OneWorld Health to continue engaging the expertise of senior
pharmaceutical executives who have already stepped forward and to
begin a dialogue with those who may not be aware of this opportunity,"
stated founder and CEO Victoria Hale, Ph.D.oneworldhealth .php/

Daniel Zimmerman, Senior Vice President of Research, Cellular Immunology
of CEL-SCI commented, "We believe that there could be significant potential
for CEL-1000 as a possible treatment for viral encephalitis.

diseases health

corporate-ir. Idenix's headquarters are located in Cambridge, Massachusetts
and it has drug discovery operations in Montpellier, France and Cagliari,
Italy.
The Institute for OneWorld Health, headquartered in San Francisco,
Calif. corporation
(http://www. Earlier studies
in Dr.

infectious conditions

, today announced it received a grant from the Sapling Foundation
(Woodside, Calif .org/). In
the United States, the most frequently reported causes are herpes simplex
virus type 1 (HSV-1) and viruses spread by insects."
CEL-1000 is a modified version of a human immune-based protein known to
bind to both human and mouse immune cells and appears to act by enhancing the
host 's protective immune response.

support lyme

OneWorld Health Awarded Sapling Foundation Grant; Nonprofit Pharmaceutical to Engage Industry in Global Health Partnerships

S. "OneWorld Health has
already benefited from the generosity of people involved with the
pharmaceutical industry through donations of time, resources ,
expertise and drug leads. nonprofit
pharmaceutical company, develops new, affordable medicines for
infectious diseases that disproportionately affect people in the
developing world, including visceral leishmaniasis, malaria, diarrhea
and Chagas disease. Media resources are available at
http: //www. VIENNA, Va. Kenneth S.
These studies suggest that CEL-1000 modulates the immune system to more
effectively fight different diseases.

spirochetal mycoplasmal

, Idenix's chairman and chief executive officer, will present
a corporate overview at the upcoming SG Cowen 25th Annual Health Care
Conference on March 17, 2005 at 9:40 a.zhtml?ticker=IDIX+item_id=1031417
or under "Calendar of Events" in the Idenix Investor Center at
http://www. The archived replay will be available on the Idenix
website for two weeks following the presentation."
Among the world's poorest people, six in 10 die of infectious
diseases .
The Institute for OneWorld Health, the first U. Rosenthal's lab with Dr.
CEL-SCI Corporation is developing new immune system based treatments for
cancer and infectious diseases.

support groups

, Idenix
Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Jean-Pierre
Sommadossi, Ph .
The live and archived webcast of the presentation can be accessed at
http://www.idenix.oneworldhealth .S. Rosenthal, Professor of Microbiology and Immunology, and Dr. Antiviral drugs are available
for the treatment of herpes simplex virus infections, but antiviral drugs are
not available for other encephalitis causing viruses.

diseases disease

D.com.S., CEL-SCI CORPORATION
(Amex: CVM) announces that its CEL-1000 immune-modulating peptide was shown in
mice to protect against viral encephalitis, a potentially lethal inflammation
of the brain. The Company undertakes no
obligation to publicly release the result of any revision to these forward-
looking statements which may be made to reflect the events or circumstances
after the date hereof or to reflect the occurrence of unanticipated events.

disease spirochetal

Contact:
Idenix Pharmaceuticals, Inc.) to further engage the pharmaceutical industry in
global health partnerships to benefit developing countries.
Malaria still infects at least 500 million people each year., is a tax-exempt 501(c) (3) U. Factors
that could cause or contribute to such differences include, an inability to
duplicate the clinical results demonstrated in clinical studies, timely
development of any potential products that can be shown to be safe and
effective , receiving necessary regulatory approvals, difficulties in
manufacturing any of the Company's potential products, inability to raise the
necessary capital and the risk factors set forth from time to time in CEL-SCI
Corporation's SEC filings, including but not limited to its report on Form 10-
K/A for the year ended September 30, 2004.

disease health

For example, diarrhea kills two million children each year. These data were presented yesterday by
Dr. Other researchers have shown
that CEL-1000 also protects against malaria and cancer in animal models.

herpes lyme

Idenix Pharmaceuticals to Present at the SG Cowen 25th Annual Health Care Conference

ET at the The Boston Marriott Copley
Place, Boston, MA.

About Idenix:
Idenix Pharmaceuticals, Inc.
Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838

This is
the second such grant from the Foundation in support of fostering
collaborations with executive and scientific talent from industry. And
visceral leishmaniasis , a fatal disease that is transmitted by sand
flies, infects an estimated 1.5 million people worldwide .org/media/index. Viral encephalitis is on the U.S.

mycoplasmal viral

CAMBRIDGE, Mass. We look forward to more collaborations as a
means to fulfill our goal of bringing forth new medicines for people
in the developing world . OneWorld Health applies its entrepreneurial
business model with a staff of experienced pharmaceutical scientists
that identifies promising leads and drives development from
pre-clinical studies to clinical trials through regulatory approval.S.
Neena Goel at Northeastern Ohio Universities College of Medicine, Rootstown,
Ohio at the American Association of Immunologists Annual Meeting in San Diego .
More than 100 different types of viruses can cause acute encephalitis. government has included in the
second highest level immediate risk category for use as biological weapons --
The Venezuelan Equine Encephalitis (VEE), the Eastern Equine Encephalitis
(EEE) and Western Equine Encephalitis (WEE). Such statements are subject to risks and uncertainties which
could cause actual results to differ materially from those projected.